US Patent Issued to Scancell on March 25 for "Anti-tumour response to modified self-epitopes" (British Inventors)

ALEXANDRIA, Va., March 26 -- United States Patent no. 12,258,377, issued on March 25, was assigned to Scancell Ltd. (Oxford, Great Britain).

"Anti-tumour response to modified self-epitopes" was invented by Linda Gillian Durrant (Nottingham, Great Britain), Victoria Anne Brentville (Nottingham, Great Britain) and Rachael Louise Metheringham (Nottingham, Great Britain).

According to the abstract* released by the U.S. Patent & Trademark Office: "Anti-tumour immune responses to modified self-epitopes. The present invention relates to the use of tumour-associated epitopes in medicine and in particular in the treatment of cancer. The epitopes stimulate an immune reaction against the tumour and have a modification selected from deimination of ar...